Clinical trials: Immune Surveillance
Multiple Myeloma
Korean Post Marketing Surveillance for ELREXFIO (Elranatamab).
This study is to assess the safety and effectiveness of Elranatamab in the real-world clinical settings for the treatment of patients with multiple myeloma in Korea.
- Trial name
- NCT06581848
- Testing
- Elranatamab
- Where
- South Korea
- Volunteers
- 150 people
- Sponsor
- Pfizer
Diabetes Mellitus, Type 1
General Use-results Surveillance With Awiqli in Patients With Diabetes Mellitus
The purpose of the study is to investigate the safety and effectiveness of Awiqli in participants with diabetes mellitus under real world clinical practice in Japan. Participants will get Awiqli as prescribed by the study doctor.
- Trial name
- NCT06807190
- Testing
- Insulin Icodec
- Where
- 116 sites in Japan
- Volunteers
- 630 people
- Sponsor
- Novo Nordisk A/S